Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Estonia

Cambrex Snaps Up Estonian API Firm

January 2008 | Industry News

US healthcare firm Cambrex has acquired, through its Swedish subsidiary Cambrex Karlskoga, Estonian active pharmaceutical ingredient (API) producer ProSyntest, as it seeks as to strengthen its European operations.

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries